Structural Basis for C8 methylation of 23S ribosomal RNA by Cfr

Using a transient protein-RNA crosslink and Cryo-EM, researchers determined the 3.0 Å structure of the antibiotic resistance enzyme Cfr bound to an L-shaped rRNA fragment, revealing the structural basis for its unique C8 methylation activity.

The Gist

The Big Picture: A Tiny Locksmith and a Super-Strong Shield

Imagine bacteria as tiny factories that build machines (ribosomes) to make proteins. Antibiotics are like saboteurs that sneak into these factories and jam the machines, stopping the bacteria from growing.

However, some bacteria have a "super-villain" tool called Cfr. Think of Cfr as a tiny, highly skilled locksmith. Its job is to sneak into the bacterial factory and put a special "shield" (a methyl group) on a specific part of the machine (a piece of RNA called A2503).

Once this shield is in place, the antibiotics can't grab onto the machine anymore. It's like putting a piece of bubble wrap over a keyhole; the key (antibiotic) can't fit, so the bacteria survive. This is why infections caused by these bacteria are so hard to treat.

The Mystery: We Couldn't See the Thief

Scientists have known about this locksmith (Cfr) for a long time, but they couldn't see exactly how it works. It's like trying to understand how a pickpocket steals a wallet without ever seeing the pickpocket's hands.

The problem was that Cfr is too small.

• The Size Problem: Most high-tech cameras (Cryo-EM) used to take pictures of tiny molecules need the object to be big (like a bus) to get a clear photo. Cfr is the size of a bicycle. When you try to photograph a bicycle with a camera designed for buses, the picture comes out blurry.
• The Instability Problem: Even if they could see it, the locksmith is very fast. It grabs the RNA, does its job, and lets go immediately. By the time the camera clicks, the locksmith has already left the scene.

The Clever Trick: Gluing the Thief to the Scene

To solve this, the scientists used a clever trick. They knew that during the theft, the locksmith briefly glues itself to the machine. But usually, a specific part of the locksmith (a tiny hook called Cys105) snaps the glue off so the locksmith can leave.

The scientists did two things:

1. Cut the Hook: They mutated the Cfr enzyme so that the "hook" (Cys105) was broken. This meant the locksmith got stuck to the machine and couldn't let go.
2. Used a Bigger Target: Instead of using the whole massive factory (the whole ribosome), they used a small, manageable piece of the machine (an 87-nucleotide strand of RNA) that still looked like the real thing.

Now, they had a frozen snapshot: The locksmith (Cfr) was permanently glued to the machine part (RNA). Because they were stuck together, the whole thing became big enough and stable enough for the high-tech camera to take a crystal-clear 3D photo.

What They Saw: The "L-Shape" Surprise

When they finally looked at the photo, they saw something fascinating:

1. The Shape Shift: The piece of RNA they used didn't look like a straight stick. It folded up into an "L" shape, looking exactly like a tRNA (a different type of molecule that usually helps build proteins).

   • Analogy: Imagine a long piece of string. You'd expect it to be straight. But when the locksmith grabs it, the string folds into an "L" shape, just like a folded piece of paper. The locksmith actually prefers the RNA to be folded this way to do its job.

2. The Grip: The locksmith doesn't care about the specific letters (the sequence) on the RNA. Instead, it cares about the shape and the skeleton (the backbone) of the RNA. It's like a glove that fits any hand as long as the fingers are in the right position, regardless of what the skin looks like.

3. The Active Site: They saw exactly where the "shield" is placed. The RNA twists and turns (a "U-turn") to tuck the target spot (A2503) right into the locksmith's hand. The locksmith then reaches in and attaches the methyl group.

Why This Matters

This paper is a breakthrough for two main reasons:

• We finally see the mechanism: We now know exactly how Cfr grabs the RNA and puts the shield on. It's like finally seeing the pickpocket's hand in the act.
• New ways to fight back: Now that we know exactly how the locksmith works, drug designers can try to build a "fake key" or a "super-glue" that jams the locksmith's hand. If we can stop Cfr from putting the shield on, the antibiotics will work again, and we can cure these super-bug infections.

In summary: Scientists took a tiny, fast-moving enzyme, glued it to a piece of RNA, and took a high-resolution photo. They discovered that the RNA folds into an "L" shape to fit the enzyme, revealing the secret handshake that allows bacteria to resist our best medicines.

Technical Summary

1. Problem Statement

• Antibiotic Resistance: The enzyme Cfr (encoded by the cfr gene) is a major driver of multidrug resistance in bacteria. It methylates the C8 position of adenosine 2503 (A2503) in the 23S ribosomal RNA (rRNA). This modification confers resistance to five or more classes of clinically critical antibiotics, including phenicols, lincosamides, oxazolidinones (e.g., linezolid), pleuromutilins, and streptogramins.
• Structural Knowledge Gap: Despite over a decade of attempts, no high-resolution structure of an active, wild-type Cfr protein has been determined via X-ray crystallography. Furthermore, while the homologous enzyme RlmN (which methylates C2 of A2503) has been structurally characterized, no structure exists for RlmN or Cfr bound to a fragment of 23S rRNA.
• Technical Challenge: Cfr is a small protein (36–40 kDa), which falls below the typical size threshold (100 kDa) for high-resolution single-particle cryogenic electron microscopy (Cryo-EM) due to low signal-to-noise ratios and difficulties in particle alignment.

2. Methodology

To overcome the size limitation and capture the catalytic intermediate, the authors employed a multi-faceted approach:

• Trapping the Catalytic Intermediate: The authors utilized the known radical S-adenosylmethionine (SAM) mechanism of Cfr. They engineered a Cfr C105A variant (replacing the catalytic Cysteine 105 with Alanine). In the wild-type enzyme, C105 is required to resolve the covalent protein-RNA crosslink formed during catalysis. The C105A mutation traps the enzyme in a stable, covalently crosslinked state with its substrate.
• Substrate Engineering: An 87-nucleotide (87-mer) fragment of 23S rRNA (spanning nucleotides 2496–2582) was synthesized. This fragment includes the target A2503 and forms stems H90, H91, and H92.
• Cryo-EM Sample Preparation:
  • Graphene Monolayers: To protect the small Cfr particles from the air-water interface and improve contrast, the authors used chemical vapor deposition (CVD) graphene monolayer grids.
  • Beam-Induced Motion Suppression: The graphene grids minimized beam-induced motion to sub-0.5–1 Å levels, eliminating the need for particle polishing.
  • Aerobic Handling: Despite Cfr's oxygen sensitivity, the rRNA substrate provided sufficient protection to allow grid preparation with <1 minute of air exposure.
• Data Collection and Processing: Single-particle analysis (SPA) was performed using Cryo-EM, achieving a resolution of 3.02 Å (local resolution 2.9–3.3 Å). 3D variability analysis (3DVA) was used to assess conformational flexibility.

3. Key Contributions

• First High-Resolution Structure of Cfr: This study presents the first atomic-level structure of Cfr, specifically the C105A/87-mer rRNA crosslinked complex.
• Mechanistic Insight into Substrate Recognition: The structure reveals how a radical SAM enzyme recognizes a specific rRNA sequence within a larger structural context, distinguishing between sequence-specific and shape-specific recognition.
• Explanation of Regioselectivity: The structure provides a structural basis for why Cfr methylates the C8 position of A2503, whereas its homolog RlmN methylates the C2 position, despite their high sequence and structural similarity.

4. Key Results

• Overall Architecture:
  • The Cfr structure shares a high degree of similarity with E. coli RlmN (RMSD of 1.1 Å over 229 Cα-atoms).
  • It consists of an N-terminal domain (HhH2 fold) and a C-terminal Radical SAM (RS) domain with a partial TIM barrel fold.
  • Unlike RlmN, Cfr lacks a C-terminal helix and possesses a unique, positively charged loop extension between $\alpha$5 and $\beta$6 in the RS domain, likely involved in binding large rRNA substrates.
• RNA Conformation (The "L-Shape"):
  • The bound 87-mer rRNA adopts an L-shaped conformation that mimics the structure of tRNA (specifically tRNA$^{Glu}$ bound to RlmN), rather than the conformation it holds in the assembled 70S ribosome.
  • This suggests the rRNA undergoes a ~180° flip in the H91/H92 regions during ribosome maturation.
• Protein-RNA Interactions:
  • N-terminal Domain: Binds the H91 stem primarily through interactions with the phosphate and sugar backbones (not specific bases), stabilizing the RNA tertiary structure. Key residues include Tyr24, Arg25, and Lys49.
  • RS Domain: Specifically coordinates the H90 stem. Positively charged residues (Arg184, Arg185, Lys250) form hydrogen bonds and cation-$\pi$ interactions with the RNA backbone and bases.
  • Active Site: The target nucleotide A2503 is positioned in a "U-turn" region deep within the active site. The structure captures the crosslinked intermediate where a methylene group connects Cys338 (from the enzyme) to C8 of A2503.
• Regioselectivity Mechanism:
  • Comparison with the RlmN-tRNA structure reveals that A2503 in the Cfr complex undergoes a 180° flip relative to the position of A37 in the RlmN-tRNA complex.
  • This flip orients the C8 atom toward the catalytic center for methylation.
  • Steric Clash: Superimposing the structures suggests that Cfr residues (Tyr252, Lys318, Thr325) would sterically clash with the anticodon loop of tRNA, explaining why Cfr cannot methylate tRNA substrates, whereas RlmN can.

5. Significance

• Understanding Resistance: The structure elucidates the precise molecular mechanism by which Cfr modifies the ribosome to block antibiotic binding, providing a foundation for designing next-generation antibiotics that can bypass this resistance mechanism.
• Methodological Breakthrough: The study demonstrates that Cryo-EM can successfully resolve structures of small proteins (~40 kDa) when coupled with covalent crosslinking strategies and advanced grid technologies (graphene monolayers). This opens new avenues for studying other small, transient enzyme-substrate complexes.
• Evolutionary Insight: The findings highlight how subtle differences in active site residues and substrate orientation (the 180° flip) dictate the specific regioselectivity (C8 vs. C2 methylation) between highly homologous enzymes, offering a model for understanding enzyme evolution within the radical SAM superfamily.